Employee-Paid

AI is a way for industry players to cut costs, manage risk, and modernize health care infrastructure, while value remains a top priority for purchasers and patients, according to a new PwC report.

Many hospitals are adding billions of dollars in fees for routine care in outpatient centers they own, raising patient costs for colonoscopies, mammograms and heart screenings, a new investigation found.

The savings are not yet realized, says the Congressional Budget Office, which projects a 10-year cumulative savings of $161 billion from the phased-in drug negotiation, as well as a rebate for price increases above the inflation rate.

The $35 insulin cap reduces out-of-pocket costs for those with health savings accounts but new policies are needed to improve access to affordable insulin among commercially insured patients, says a new study.

Benefytt Technologies, operating under various names such as Health Insurance Innovations, used aggressive marketing in a scheme to lure consumers in search of Obamacare health plans, says the Federal Trade Commission.

The city of Baltimore, which paid more than $11 million in 2023 for diabetes medications through its self-funded plan, is suing the drug manufacturers, for allegedly conspiring to artificially hike the price of insulin.